CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

SHE:300765 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 7, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	55,202	37,029	42,873	9,767	8,376	7,858
Market Cap Growth	33.56%	-13.63%	338.97%	16.61%	6.59%	10.06%
Enterprise Value	54,447	36,671	39,717	7,864	6,725	6,463
Last Close Price	39.64	26.58	30.25	7.19	6.92	6.45
PE Ratio	-	689.22	98.69	13.45	21.30	26.21
PS Ratio	26.35	18.69	16.89	3.72	4.53	5.97
PB Ratio	13.25	8.24	7.82	2.48	2.54	2.93
P/TBV Ratio	15.92	10.56	8.49	2.51	2.59	3.00
P/FCF Ratio	-	-	306.85	18.54	86.64	33.97
P/OCF Ratio	-	-	59.45	15.24	28.68	22.51
EV/Sales Ratio	25.99	18.51	15.64	2.99	3.64	4.91
EV/EBITDA Ratio	-	-	128.72	9.60	13.34	16.26
EV/EBIT Ratio	-	-	258.24	10.53	15.46	18.78
EV/FCF Ratio	-75.59	-	284.26	14.93	69.57	27.94
Debt / Equity Ratio	0	0	0	0.01	0	-
Debt / EBITDA Ratio	-	-	0.01	0.02	0.00	-
Debt / FCF Ratio	-	-	0.01	0.04	0.01	-
Asset Turnover	0.35	0.29	0.42	0.63	0.55	0.45
Inventory Turnover	3.27	3.71	5.98	5.97	5.59	4.97
Quick Ratio	1.01	1.58	2.28	5.00	5.31	7.54
Current Ratio	1.54	1.95	2.42	5.48	6.09	8.17
Return on Equity (ROE)	-12.72%	-6.08%	2.67%	20.07%	13.12%	11.75%
Return on Assets (ROA)	-6.48%	-2.56%	1.59%	11.22%	8.12%	7.41%
Return on Capital (ROIC)	-8.67%	-3.46%	2.03%	12.86%	9.08%	8.43%
Return on Capital Employed (ROCE)	-14.30%	-6.00%	2.80%	18.70%	13.00%	12.60%
Earnings Yield	-0.20%	0.14%	1.01%	7.44%	4.70%	3.82%
FCF Yield	-1.30%	-4.63%	0.33%	5.39%	1.15%	2.94%
Dividend Yield	0.05%	0.07%	0.88%	0.97%	1.00%	0.55%
Payout Ratio	-	696.42%	22.52%	11.30%	10.68%	9.34%
Buyback Yield / Dilution	0.71%	-0.16%	-4.50%	0.02%	-13.53%	-6.56%
Total Shareholder Return	0.76%	-0.08%	-3.62%	0.98%	-12.53%	-6.01%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.